NETRI announced that it has received 8 million in a round of funding on March 3, 2022. The transaction included participation from new investor Neovacs S.A. for 2 million and other historic shareholders, new private and industrial investors. The investor Neovacs S.A. has an option to invest additional 1 million subject to achievement of objectives and according to needs of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EUR | -1.00% | -1.00% | -1.00% |
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- ALNEV Stock
- ALNEV Stock
- News NEOVACS
- NETRI announced that it has received €8 million in funding from Neovacs S.A., and other investors